Element (range) | All | Mixture pattern ≦12 months | Mixture pattern >12 months | |||
---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | |
1. Clinical knowledge of A-CRA (0–1) | 0.70 | 0.21 | 0.68 | 0.23 | 0.72 | 0.18 |
2. A-CRA dosage (0–1) | 0.44 | 0.50 | 0.33 | 0.49 | 0.50 | 0.51 |
3. Clinical staff penetration (0–1) | 0.35 | 0.40 | 0.22 | 0.37 | 0.49 | 0.38 |
4. Presence of certified A-CRA supervisor(s) (0–1) | 0.77 | 0.42 | 0.61 | 0.49 | 0.92 | 0.27 |
5. Recommended frequency of clinical supervision (0–1) | 0.57 | 0.50 | 0.71 | 0.46 | 0.45 | 0.51 |
6. Recommended clinical supervision content (0–1.5) | 1.06 | 0.34 | 1.11 | 0.39 | 1.02 | 0.30 |
7. Review and feedback on treatment sessions (0–4) | 2.12 | 1.97 | 2.71 | 1.86 | 1.70 | 1.98 |
8. Clinical supervisors’ knowledge of A-CRA training and certification process (0–1) | 0.30 | 0.33 | 0.24 | 0.31 | 0.36 | 0.34 |
9. On-site A-CRA training quality (0–1) | 0.15 | 0.24 | 0.00 | 0.00 | 0.15 | 0.24 |
10. Youth penetration (0–1) | 0.40 | 0.40 | 0.20 | 0.35 | 0.58 | 0.36 |